Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple walking test predict fall risk in multiple sclerosis?

NCT ID NCT07788859

Knowledge-focused Sponsor: Afyonkarahisar Health Sciences University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This study tests three versions of a dual-task walking test in people with multiple sclerosis. The test combines the standard Timed Up and Go, where a person stands, walks three meters, turns, and sits, with a second task like counting backward, naming words, or carrying a ball on a tray. Researchers want to see which version is most reliable and valid for measuring dual-task performance, which relates to fall risk. The study includes 40 adults with MS who do not need walking aids.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Three dual-task Timed Up and Go (DTUG) protocols: counting backward, verbal fluency, and carrying a ball on a tray, each combined with the standard Timed Up and Go test.
What this could lead to
If one protocol proves reliable and valid, it could become a standard tool for assessing fall risk and dual-task performance in people with multiple sclerosis.
What could go wrong
This is a small, early-stage measurement study, not a treatment trial. The findings may not apply to people with more severe disability or to other settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants will be recruited from among individuals who visit the outpatient clinic of the Department of Neurology at SANKO University.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Having been diagnosed with MS according to the McDonald criteria revised in 2017, * Being between the ages of 18 and 65, * Having an Expanded Disability Status Scale (EDSS) score between 0 and 5.5, * Not requiring any assistive walking devices. Exclusion Criteria: * Pregnancy; * Having experienced a relapse within the past three months; * The presence of another neurological condition in addition to MS; * The presence of a different disorder that could potentially affect gait parameters; * The presence of visual, auditory, perceptual, or cognitive impairments severe enough to interfere with the test administration

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Multiple sclerosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • SANKO University

    RECRUITING

    Gaziantep, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.